Pozen looks to fight off Anchen patent challenge - Triangle Business Journal

Chapel Hill-based drug developer Pozen says in a recent filing with the SEC that it will vigorously defend its patents from any infringement,” with regards to Vimovo, an arthritis drug it developed with AstraZeneca. Last week, Anchen harmaceuticals Inc. announced its intentions to file an abbreviated new drug application for a generic version of Vimovo. In a filing with the Securities and Exchange Commission, Anchen says its “generic...